Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: Psychopharmacology (Berl). 2013 Jun 4;230(2):10.1007/s00213-013-3153-2. doi: 10.1007/s00213-013-3153-2

Fig 4 — Effect of low doses of AMPA (0.5 mg/kg), ketamine (0.5 mg/kg), and their combination on markers of neurogenesis (BDNF), synaptogenesis (synapsin), and the signal transduction protein (mTOR) in the hippocampus. (a) Immunoblots, (b) BDNF, (c) synapsin, (d) mTOR. Values are mean ± SEM, *p<0.05 **p<0.01 compared to SAL, n=7–8.

Fig 4 — Effect of low doses of AMPA (0.5 mg/kg), ketamine (0.5 mg/kg), and their combination on markers of neurogenesis (BDNF), synaptogenesis (synapsin), and the signal transduction protein (mTOR) in the hippocampus. (a) Immunoblots, (b) BDNF, (c) synapsin, (d) mTOR. Values are mean ± SEM, *p<0.05 **p<0.01 compared to SAL, n=7–8.